Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) |
| BNF code | 0601021M0BQAAAM |
| Virtual Medicinal Product | Gliclazide 30mg modified-release tablets |
| Name | Lamzarin 30mg modified-release tablets |
| Supplier | Key Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets | |
| Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.